No abstract

No abstract

No abstract

The aim of this work is to investigate a new mathematical model that describes the interactions between Hepatitis B virus (HBV), liver cells (hepatocytes), and the adaptive immune response. The qualitative analysis of this as cytotoxic T lymphocytes (CTL) cells and the antibodies. These outcomes are (1) a disease free steady state, which its local stability is characterized as usual by R (0) < 1, (2) and the existence of four endemic steady states when R (0) > 1. The local stability of these steady states depends on functions of R (0). Our study shows that although we give conditions of stability of these steady states, not all conditions are feasible. This rules out the local stability of two steady states. The conditions of stability of the two other steady states (which represent the complete failure of the adaptive immunity and the persistence of the disease) are formulated based on the domination of CTL cells response or the antibody response.

We present a delay-differential equation model with optimal control that describes the interactions between human immunodeficiency virus (HIV), CD4 + T cells, and cell-mediated immune response. Both the treatment and the intracellular delay are incorporated into the model in order to improve therapies to cure HIV infection. The optimal controls represent the efficiency of drug treatment in inhibiting viral production and preventing new infections. Existence for the optimal control pair is established, Pontryagin's maximum principle is used to characterize these optimal controls, and the optimality system is derived. For the numerical simulation, we propose a new algorithm based on the forward and backward difference approximation.